Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$931M |
| 3 |
Tesla
TSLA
|
+$793M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$769M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$703M |
| 2 |
Bank of America
BAC
|
+$690M |
| 3 |
Amazon
AMZN
|
+$678M |
| 4 |
JPMorgan Chase
JPM
|
+$601M |
| 5 |
Meta Platforms (Facebook)
META
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.11% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
CALL
BridgeBio Pharma
BBIO
$15B
| $5.57M | ﹤0.01% |
78,300
+65,500
| +512% | +$3.16M |
|
3202
Beam Therapeutics
BEAM
$3.03B
| $5.57M | ﹤0.01% |
+68,204
| New | +$3.35M |
|
3203
CALL
Mohawk Industries
MHK
$8.8B
| $5.57M | ﹤0.01% |
39,500
+21,600
| +121% | +$2.6M |
|
3204
Yum! Brands
YUM
$42B
| $5.57M | ﹤0.01% |
51,277
-25,584
| -33% | -$2.61M |
|
3205
CALL
Philips
PHG
$26.1B
| $5.56M | ﹤0.01% |
126,636
-4,563
| -3% | -$188K |
|
3206
CALL
BJs Wholesale Club
BJ
$11.4B
| $5.55M | ﹤0.01% |
149,000
-66,900
| -31% | -$2.67M |
|
3207
Ligand Pharmaceuticals
LGND
$5.59B
| $5.55M | ﹤0.01% |
89,520
+83,321
| +1,344% | +$4.75M |
|
3208
PUT
Direxion Daily Small Cap Bear 3x ETF
TZA
$251M
| $5.55M | ﹤0.01% |
10,101
-747
| -7% | -$637K |
|
3209
PUT
FMC
FMC
$1.42B
| $5.55M | ﹤0.01% |
48,300
-65,800
| -58% | -$7.32M |
|
3210
iShares Micro-Cap ETF
IWC
$1.5B
| $5.55M | ﹤0.01% |
46,779
+16,784
| +56% | +$1.77M |
|
|
UFS
3211
DELISTED
DOMTAR CORPORATION (New)
UFS
| $5.55M | ﹤0.01% |
175,240
+165,115
| +1,631% | +$4.7M |
|
3212
CALL
Stem
STEM
$52.4M
| $5.54M | ﹤0.01% |
+13,545
| New | +$3.41M |
|
|
NUVA
3213
PUT
DELISTED
NuVasive, Inc.
NUVA
| $5.54M | ﹤0.01% |
98,400
+36,700
| +59% | +$1.81M |
|
3214
PUT
ProShares VIX Mid-Term Futures ETF
VIXM
$154M
| $5.54M | ﹤0.01% |
150,900
+43,100
| +40% | +$1.64M |
|
3215
PUT
Ovintiv
OVV
$17.9B
| $5.54M | ﹤0.01% |
385,500
+157,200
| +69% | +$1.84M |
|
3216
Thor Industries
THO
$4.01B
| $5.53M | ﹤0.01% |
59,472
-20,219
| -25% | -$1.9M |
|
3217
St. Joe Company
JOE
$3.83B
| $5.53M | ﹤0.01% |
130,204
+117,245
| +905% | +$3.73M |
|
|
PCH
3218
CALL
DELISTED
PotlatchDeltic
PCH
| $5.53M | ﹤0.01% |
110,500
+82,400
| +293% | +$3.79M |
|
3219
CALL
Stride
LRN
$3.61B
| $5.52M | ﹤0.01% |
260,200
+1,500
| +0.6% | +$37.2K |
|
3220
Citizens Financial Group
CFG
$29.4B
| $5.52M | ﹤0.01% |
154,354
+60,464
| +64% | +$1.9M |
|
3221
CALL
Ameresco
AMRC
$1.17B
| $5.52M | ﹤0.01% |
105,600
+97,000
| +1,128% | +$4.18M |
|
3222
Rocket Pharmaceuticals
RCKT
$424M
| $5.52M | ﹤0.01% |
100,597
+87,545
| +671% | +$3.19M |
|
3223
ProShares Ultra Gold
UGL
$852M
| $5.52M | ﹤0.01% |
323,552
+13,400
| +4% | +$225K |
|
|
FLIR
3224
PUT
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $5.51M | ﹤0.01% |
125,800
-112,400
| -47% | -$4.34M |
|
|
RETA
3225
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.51M | ﹤0.01% |
44,600
-23,100
| -34% | -$3.04M |
|
Similar funds
Jeff Yass's Q4 2020 Portfolio in Review
As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
- Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
- Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
- Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
- Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
- Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.